L. Van Bortel - Concepedia

Author

L. Van Bortel

Maastricht University

Also Known As

L Van Bortel, L van Bortel, L. Van Bortel, L. v. Bortel, L. van Bortel, LM Van Bortel, LM van Bortel

Publications

399

Citations

H-Index

Concepts

All Affiliations

Maastricht University Ghent University Hospital Ghent University Maastricht University Medical Centre

About

L. Van Bortel is an author at Maastricht University specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	175
2	Nephrology	3	3	76
3	Pharmacology	3	3	142
4	Natural Sciences	1	1	99
5	Biochemistry	1	1	99

L. Van Bortel

Publications

342

Citations

H-Index

Page 1

	Year	Citations
Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects Rajesh Krishna, AJ Bergman, Bo Jin, Clinical Pharmacology & Therapeutics High-density LipoproteinHealthy SubjectsBiochemistryPharmacological StudyMedicine	2008	99
Blood pressure during the interdialytic period in haemodialysis patients: estimation of representative blood pressure values J. P. Kooman, Ulrich Gladziwa, G. Böcker, Nephrology Dialysis Transplantation	1992	94
Cranial and Peripheral Interictal Vascular Changes in Migraine Patients JN de Hoon, JM Willigers, J. Troost, Cephalalgia	2003	59
Arterial compliance in patients on long-treatment-time dialysis Antinus J. Luik, Janneke J. Spek, Bernard Charra, Nephrology Dialysis Transplantation HemodialysisHypertensionUrologyArterial ComplianceCardiovascular Disease	1997	33
Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure L. Van Bortel, R Böhm, J. M. V. Mooij, European Journal of Clinical Pharmacology UrologyRenal FunctionMedicineKidney FailurePharmacology	1989	26
Pharmacokinetics of nitrendipine in terminal renal failure L. Van Bortel, R Böhm, J. Mooy, European Journal of Clinical Pharmacology MedicineKidney FailurePharmacologyPharmacotherapyAcute Kidney Injury	1989	17
Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug-drug interactions Vibeke Krüse, Annemie Somers, L. Van Bortel, Journal of Clinical Pharmacy and Therapeutics	2014	14

Page 1